Thermo Fisher Bioproduction Insights

1. The Future Of RNA Manufacturing Starts With Raw Material Innovation 2/11/2026

   Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

2. Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy 2/6/2026

   The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

3. High Purity Alcohols In Biopharma: Insights In Navigating Compliance 1/14/2026

   Learn how to mitigate supply chain risks for industrial alcohols and ensure workplace safety through rigorous tracking and reporting protocols.

4. Avoid CapEX With Improved Operational Efficiencies 1/14/2026

   Avoid massive capital expenditures by optimizing supply chain logistics. Learn how off-site material sampling and just-in-time delivery reduce lead times from eight weeks to a single day.

5. The Importance Of Quality In Raw Material Selection 1/16/2025

   Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

6. Uninterrupted Supply To Meet Demand 1/23/2024

   Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.

7. Reducing Lead Time, Delivering >99.5% OTIF 1/23/2024

   Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth.

8. Transitioning From Using RUO To cGMP Chemicals For Clinical Trials 10/17/2023

   Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.

9. Increasing Success Rates In Your Drug Discovery Research 10/17/2023

   Learn about a reputable, highly diverse screening library and fragment collection that could pave your way through a successful discovery campaign.

10. Topliss Sets In Drug Design Technical Notes For The Medicinal Chemist 8/3/2023

    When considering new, innovative, and efficient drug design processes, you may want to review Professor J G Topliss's non-mathematical operational schemes for analogue design.